Business UpdateMay 13, 2026, 07:02 AM
Corbus Pharmaceuticals CEO to Present at RBC & Jefferies Conferences
AI Summary
Corbus Pharmaceuticals Holdings, Inc. announced that its Chief Executive Officer, Yuval Cohen, Ph.D., will present a corporate overview and participate in investor meetings at two upcoming healthcare conferences. He is scheduled to present at the RBC Capital Markets Global Healthcare Conference on May 19, 2026, and at the Jefferies Global Healthcare Conference on June 4, 2026. The company is focused on developing new therapies in oncology and obesity.
Key Highlights
- Corbus Pharmaceuticals CEO Yuval Cohen to present a corporate overview at two investor conferences.
- Presentation at RBC Capital Markets Global Healthcare Conference on May 19, 2026, at 2:05 PM EDT.
- Presentation at Jefferies Global Healthcare Conference on June 4, 2026, at 4:55 PM EDT.
- Both conferences will include one-on-one investor meetings.
- Corbus is a clinical-stage company focused on oncology and obesity therapies.
Price Impact
More from CRBP